1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 22 Hits
  • 検索条件 : 絞込み (MeSH = Carcinoma, Non-Small-Cell Lung* / drug therapy)
生物種 リソース名 タイトル
ヒト・動物細胞 A549 A stress granule-associated RNA-binding protein FAM120A drives cisplatin resistance in non-small cell lung cancer.
ヒト・動物細胞 Ba/F3 Targeting EGFR-Mcl-1 Axis by Piperlongumine as a Novel Strategy for Non-Small Cell Lung Cancer Therapy.
ヒト・動物細胞 Ba/F3(RCB0805) Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation.
ヒト・動物細胞 T98G(RCB1954) The dynamic relationship between inorganic polyphosphate and adenosine triphosphate in human non-small cell lung cancer H1299 cells.
ヒト・動物細胞 EBC-1(RCB1965) PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer.
ヒト・動物細胞 LK-2(RCB1970) Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228.
ヒト・動物細胞 II-18(RCB2093) Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β.
ヒト・動物細胞 A549(RCB0098) , HCT116(RCB2979) Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells.
ヒト・動物細胞 EBC-1(RCB1965) Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer.
ヒト・動物細胞 293T(RCB2202) Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer.
実験動物マウス RBRC09497 Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.
ヒト・動物細胞 PC-14(RCB0446) Suppression of non-small-cell lung cancer A549 tumor growth by an mtDNA mutation-targeting pyrrole-imidazole polyamide-triphenylphosphonium and a senolytic drug.
ヒト・動物細胞 A549(RCB0098) Nrf2/p‑Fyn/ABCB1 axis accompanied by p‑Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non‑small cell lung cancer.
ヒト・動物細胞 Lu99(RCB1900) , LU65(RCB1967) Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer.
ヒト・動物細胞 Ba/F3(RCB0805) Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
ヒト・動物細胞 PC-9(RCB4455) , MRC-5 MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements.
ヒト・動物細胞 PC-9(RCB4455) , Jurkat(RCB3052) A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations.
ヒト・動物細胞 Ba/F3(RCB0805) , WEHI-3(RCB0035) Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation.
ヒト・動物細胞 Ba/F3(RCB0805) Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer.
ヒト・動物細胞 PC-9(RCB4455) Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells.